Will the government invest in medicines manufacturing centres of excellence?
A pharma group is pressing the government for help to build four medicines manufacturing centres of excellence across the UK.
The Medicines Manufacturing Industry Partnership (MMIP)* says the centres would provide high-skilled jobs and help plug gaps in the UK’s capabilities in areas like diagnostics and packaging, advanced therapy production and small molecule processing.
In a report, Page Content
Manufacturing vision for UK pharma, the MMIP sets out a list of things it wants, including:
- a medicines manufacturing innovation centre in Scotland capable of providing a clinical supply of medicines and further develop manufacturing capabilities
- an open-access site to allow the manufacturing of complex medicines and handling of high-potency materials
- a centre to support the development of the next generation of packaging technology and smart devices required for new types of medicines
- continued support for a centre for manufacturing cutting-edge specialised cell and gene therapies
MMIP says the government has already set-aside an investment of £197m over four years to develop technologies for the manufacture of medicines that will speed up patient access to new drugs and treatments.
*MMIP represents the voice of medicines manufacturers in the UK. It was established jointly by the government and the biopharmaceutical industry in 2014.
Association of the British Pharmaceutical Industry (ABPI): Invest in cutting-edge R&D centres and make UK best place in the world for future medicines
ABPI: Manufacturing vision for UK pharma: Future proofing the UK through an aligned technology and innovation road map
Gov.uk: Business Secretary announces industrial strategy challenge fund investments